Physician profile
Jack Z Wang
NPI 1740272368
$3,968.94
in general payments reported to CMS, 2019-2025
16 companies · $760 in 2025
The $760 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $31.33 · 2021: $202 · 2022: $956 · 2023: $950 · 2024: $866 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,226 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,225.57 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $896.35 | 2021-2024 | Myrisk |
| Dendreon Pharmaceuticals LLC | $530.99 | 2019-2024 | Provenge |
| Novartis Pharmaceuticals Corporation | $484.81 | 2023-2025 | |
| Teleflex LLC | $460.30 | 2025 | Barrigel |
| Boston Scientific Corporation | $410.82 | 2019-2024 | Spaceoar Vue System - 10ml |
| Janssen Biotech, INC. | $305.23 | 2020-2025 | Erleada |
| Sumitomo Pharma America, INC. | $270.91 | 2023-2024 | Orgovyx |
| Myovant Sciences INC. | $215.06 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.77 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $90.11 | 2022-2025 | Keytruda |
| Blue Earth Diagnostics | $56.50 | 2019-2023 | |
| Urogen Pharma, INC. | $54.87 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $23.60 | 2019 | |
| Pfizer INC. | $19.17 | 2020 | |
| Abbvie INC. | $18.79 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $16.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.